Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 |
filingDate |
2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110845574-B |
titleOfInvention |
Polypeptide and application thereof |
abstract |
The invention relates to a polypeptide compound Phe-Pro-Ser-Ile-Val-Gly-Arg-Pro for inhibiting dipeptidyl peptidase (DPP-IV) activity, Prolyl Endonuclease (PEP) and reducing blood sugar and resisting Alzheimer's disease, and the amino acid sequence of the polypeptide compound is Phe-Pro-Ser-Ile-Val-Gly-Arg-Pro. The polypeptide Phe-Pro-Ser-Ile-Val-Gly-Arg-Pro has DPP-IV and PEP inhibitory activity, blood sugar reducing and memory improving activity, and has good application prospect when being used as a medicine lead compound for reducing blood sugar, improving memory and resisting Alzheimer's disease. |
priorityDate |
2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |